Heart Failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Voluntarily sign the informed consent and perform their duties; (2) Discharged patients who meet the diagnostic criteria and participate in the test voluntarily during their stay in hospital; (3) The condition is relatively stable and can be discharged from hospital and followed up; (4) in patients with cardiac function II ~ III level; (5) The age of the patient is >= 45 and <= 85 years of age, regardless of gender; Only those who meet the above criteria can be included in the observed cases. None of them is necessary.
Exclusion criteria
Exclusion criteria: (1) Patients with failure of lung, liver, kidney and other important organs, namely heart failure caused by non-cardiac origin; (2) Patients with congenital heart disease, constrictive pericarditis, severe pulmonary hypertension, obvious valvular disease, patients requiring cardiac resynchronization therapy; (3) Patients with severe primary medical diseases such as liver, kidney and hematopoietic system; (4) persons with mental or legal disabilities; (5) Have participated in or will participate in other drug clinical studies; (6) Living a bad life, such as being a chronic alcoholic or a drug addict; (7) pregnant and lactating women; (8) As judged by the researcher, it is not suitable to participate in this experiment; Those who meet 1 of the above conditions cannot be taken as subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate;Blood pressure;N terminal pro B type natriuretic peptide (NT-pro-BNP);The six-minute walk is the test distance (6MWT);Left ventricular ejection fraction (LVEF);Ventricular remodeling parameter;Left ventricular end-diastolic diameter (LVEDD);MLFHQ; | — |
Countries
China
Contacts
Shanghai Hospital of Traditional Chinese Medicine